⌘K

Login Start Free

Home/Filings/4/0000912282-25-000695

4//SEC Filing

Thye Dirk 4

Accession 0000912282-25-000695

CIK 0001662774other

View on SEC.gov Company Profile

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 8:43 AM ET

Size

6.4 KB

Accession

0000912282-25-000695

Insider Transaction Report

Form 4

Period: 2025-06-18

Quince Therapeutics, Inc.QNCX

DirectorCEO and CMO

Transactions

Award
Warrants
2025-06-18$0.13/sh+150,944$18,868→ 150,944 total
Exercise: $1.20From: 2025-06-18Exp: 2030-06-18→ Common Shares (150,944 underlying)
Award
Common Shares
2025-06-18$1.20/sh+150,944$181,133→ 994,885 total

Documents

1 file

4
form4.xmlPrimary

Issuer

Quince Therapeutics, Inc.

CIK 0001662774

Entity typeother

Related Parties

1

filerCIK 0001638945

Filing Metadata

Form type: 4
Filed: Jun 22, 8:00 PM ET
Accepted: Jun 23, 8:43 AM ET
Size: 6.4 KB

View on SEC.gov